Healthcare - Biotechnology - NASDAQ - US
$ 36.45
-0.274 %
$ 2.71 B
Market Cap
-7.81
P/E
BALANCE SHEET
726 M
ASSETS
99.6 M
LIABILITIES
626 M
EQUITY
BALANCE SHEET DECOMPOSITION
Balance Sheet Decomposition
SpringWorks Therapeutics, Inc.
| Current Assets | 501 M |
| Cash & Short-Term Investments | 479 M |
| Receivables | 5.93 M |
| Other Current Assets | 15.8 M |
| Non-Current Assets | 225 M |
| Long-Term Investments | 185 M |
| PP&E | 24.1 M |
| Other Non-Current Assets | 15.4 M |
| Current Liabilities | 78.2 M |
| Accounts Payable | 7.4 M |
| Short-Term Debt | 2.12 M |
| Other Current Liabilities | 68.7 M |
| Non-Current Liabilities | 21.4 M |
| Long-Term Debt | 6 M |
| Other Non-Current Liabilities | 15.4 M |
Balance Sheet
Millions
| Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | Dec-2018 | Dec-2017 | |
|---|---|---|---|---|---|---|---|
| ASSETS | |||||||
| Cash & Cash Equivalents | 176.1 | 67.5 | 104.0 | 147.1 | 327.7 | 45.6 | 10.3 |
| Short Term Investments | 303.1 | 524.7 | 269.5 | 361.4 | 0 | 0 | 0 |
| Receivables | 5.9 | 0 | 0 | 0 | 0 | 0 | 0 |
| Inventory | 3.1 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Assets | 12.7 | 7.5 | 18.8 | 9.8 | 7.4 | 1.4 | 0.3 |
| Total Current Assets | 500.9 | 599.8 | 382.9 | 513.4 | 331.4 | 47.0 | 10.5 |
| PP&E | 24.1 | 18.3 | 4.2 | 3.0 | 0.8 | 0.3 | 41 K |
| Intangible Assets | 11.2 | 0 | 0 | 0 | 0 | 0 | 0 |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long Term Investments | 185.3 | 9.0 | 62.1 | 57.2 | 1.0 | 0 | 0 |
| Other Long Term Assets | 4.2 | 3.2 | 3.3 | 2.6 | 1.7 | 1.0 | 0 |
| Other Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Assets | 725.8 | 630.2 | 452.5 | 576.2 | 334.8 | 48.4 | 10.6 |
| LIABILITIES | |||||||
| Accounts Payable | 7.4 | 8.0 | 3.4 | 1.4 | 2.7 | 0.8 | 0.3 |
| Short Term Debt | 2.1 | 1.0 | 2.3 | 2.8 | 0 | 0 | 0 |
| Other Current Liabilities | 64.5 | 38.8 | 24.2 | 13.5 | 9.3 | 2.9 | 0.4 |
| Total Current Liabilities | 78.2 | 51.0 | 30.0 | 17.6 | 12.0 | 3.7 | 0.7 |
| Long Term Debt | 6.0 | 4.8 | 0.1 | 1.4 | 0 | 0 | 0 |
| Deferred Tax Income | 0 | (16.2) | 0 | 0 | 0 | 0 | 0 |
| Other Liabilities | 0 | 0 | 0 | 0.2 | 0.8 | 64.1 | 12.6 |
| Total Liabilities | 99.6 | 72.0 | 30.1 | 19.1 | 12.8 | 67.8 | 13.2 |
| EQUITY | |||||||
| Common Stock | 7 K | 6 K | 5 K | 5 K | 4 K | 1 | 0 |
| Retained Earnings | (895.0) | (569.9) | (292.5) | (118.6) | (73.0) | (22.5) | (4.6) |
| Other Accumulative Comprehensive Income/Loss | 1.2 | (0.8) | (0.3) | 41 K | (334.8) | 0 | 0 |
| Total Equity | 626.2 | (569.9) | 422.4 | 557.1 | 322.1 | (19.4) | (2.6) |
| Total Liabilities and Equity | 725.8 | (497.9) | 452.5 | 576.2 | 334.8 | 48.4 | 10.6 |
| SHARES OUTSTANDING | |||||||
| Common Shares Outstanding | 63.1 | 53.3 | 48.5 | 43.3 | 43.0 | 22.2 | 43.2 |